Study of EVO756 in Adults With Migraine

Purpose

This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

Condition

  • Migraine

Eligibility

Eligible Ages
Between 18 Years and 64 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults aged 18 to <65 years - Migraine with or without aura, per ICHD-3 criteria - History of failure with prior preventive migraine treatments - Not currently using migraine preventive therapy

Exclusion Criteria

  • Difficulty distinguishing migraine from other headache types or presence of other primary headache disorders - Use of certain medications - Any clinically significant medical, psychiatric, neurological, cardiovascular, or laboratory abnormalities

Study Design

Phase
Phase 2
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Dose 1
Orally administered EVO756, Dose 1 (Daily)
  • Drug: EVO756, Dose 1
    Orally administered EVO756, Dose 1 (Daily)
Experimental
Dose 2
Orally administered EVO756, Dose 2 (Daily)
  • Drug: EVO756, Dose 2
    Orally administered EVO756, Dose 2 (Daily)
Placebo Comparator
Placebo
Placebo control (Daily)
  • Drug: Placebo
    Placebo Control (Daily)

Recruiting Locations

Trialsphere Corp
Chandler, Arizona 85286

Neuro Pain Research Center
Fresno, California 93710
Contact:
EVO756-MIG001 Research Site
5594379700
lflores@neuropain.com

CA Medical Clinic for Headache
Los Angeles, California 90067
Contact:
EVO756-MIG001 Research Site
(323)879-9999
jlatorre@clinicalri.net

Diablo Clinical Research dba Flourish Research
Walnut Creek, California 94598
Contact:
EVO756-MIG001 Research Site
9259307267
kabdullah@flourishresearch.com

New England Institute for Neurology and Headache
Stamford, Connecticut 06905
Contact:
EVO756-MIG001 Research Site
203-914-1903
annelise@neinh.com

Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida 32256
Contact:
EVO756-MIG001 Research Site
904-281-5757
bsagil@cnshealthcare.com

Apple Medical Research Group, Inc
Miami, Florida 331216
Contact:
EVO756-MIG001 Research Site
3056678434
info@applemedresearch.org

Clinical Neuroscience Solutions, Inc.
Orlando, Florida 32819
Contact:
(407) 425-5100
orlinfo@cnshealthcare.com

Accel Research Site-Decatur-Alcanza
Decatur, Georgia 30030
Contact:
EVO756-MIG001 Research Site
404-475-0552
benoit.tete@accelclinical.com

Michigan Headache and Neurological Institute
Ann Arbor, Michigan 48104
Contact:
EVO756-MIG001 Research Site
734-677-6000
research@mhni.com

Bio Behavoural health
Toms River, New Jersey 08755
Contact:
732-244-2299
jryan@bbhnj.com

Clinosis - Dent Neurologic Instite
Amherst, New York 14226
Contact:
EVO756-MIG001 Research Site
716-250-2017
abryan@dentinstitute.com

Asheville Neurology Specialists, Pa
Asheville, North Carolina 28806
Contact:
EVO756-MIG001 Research Site
(828) 210-9306
amberc@ashneuro.com

Eximia Research NC
Raleigh, North Carolina 27607
Contact:
EVO756-MIG001 Research Site
(919) 800-5154
achambers@eximiaresearch.com

Clinical Trials of South Carolina
Charleston, South Carolina 29406
Contact:
EVO756-MIG001 Research Site
843-725-5067
Info@clinicaltrialssc.com

FutureSearch Trials of Neurology
Austin, Texas 78731
Contact:
EVO756-MIG001 Research Site
(512) 380-9925
ATXClinic@fstrials.com

FutureSearch Trials of Dallas
Dallas, Texas 75251
Contact:
EVO756-MIG001 Research Site
214-361-7700
dallasleads@fstrials.com

SFF Medical Research Group LLC
Houston, Texas 77018
Contact:
EVO756-MIG001 Research Site
(832) 533-8872
nichole.baio@evommune.com

Vaught Neurological Services
Crab Orchard, West Virginia 25827
Contact:
EVO756-MIG001 Research Site
304-252-4222
research@vaughtneurology.com

More Details

Status
Recruiting
Sponsor
Evommune, Inc.

Study Contact

Nichole Baio
(650) 319-4553
nichole.baio@evommune.com